Elevance Health Inc. (ELV)
Last Price$395.5(0.3%)
Market Cap$90.7B
ELV Rating
ELV Quality rating performance
ELV Intrinsic Value
Key Highlights:
As of Mar 03, 2025 ELV Relative Value is $388.8, which is overvalued by 1.7%, compared to current share price of $395.5.
As of Mar 03, 2025 ELV DCF Value is $1,623.6, which is undervalued by 310.5%, compared to current share price of $395.5.
ELV Share Price History
1W 2.7%
1M (2.4%)
6M (29.2%)
YTD (16.3%)
1Y (20.5%)
3Y (12.5%)
5Y 64.1%
10Y 210.4%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
ELV Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$90.7B
$84.4B
$176.8B
$4,552.0M
Shares Outstanding
229M
Employees
104K
Growth (CAGR)
11.2%
44.6%
6.45%
(1.8%)
34.54%
Profitability
43.4%
24.1%
3.3%
2.6%
76.2%
Intrinsic Value
$1,001.8 (153.3% undervalued)
$1,618.1
$385.6
$693.4
$915.3
635.5%
Return on Capital
Financial Health
$8,288.0M
($6,274.0M)
(1.4x)
35.9x
Dividends
16.4%
1.7%
33.1%
Dec 05, 2024
Earnings
Apr 16, 2025
BEAT by 3.7%
MISS by (15.4%)
120.3%
9 Beat & 1 Miss
ELV Stock Financials
ELV Income Statement Metrics
Annual
Quarterly
LTM
ELV Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$5,808.0M -27.9% YoY
Capital Expenditure (CAPEX)
($1,256.0M) -3.1% YoY
Free Cash Flow (FCF)
$4,552.0M -32.7% YoY
ELV Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$176.8B 3.2% YoY
Cost of revenue
$19.8B (84.1%) YoY
Pre-tax income
$7,904.0M 2.4% YoY
4.5% margin
ELV Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$116.7B
Current assets ($8,288.0M, 7.1% of total)
Non-current assets ($108.4B, 92.9% of total)
$0.0 (0.0%)
$4,652.0M (4.0%)
$12.1B (10.4%)
Other non-current assets
$91.6B (78.5%)
Financial position
$20.9B
Cash & Short-term
Investments
Total Debt
ELV Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
ELV Earnings Surprises
Crunching data... Almost there!
ELV Dividends
ELV Dividend Yield
Crunching data... Almost there!
ELV Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with ELV
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
FAQ
What is Elevance Health Inc. (ELV) stock rating?
As of today, Elevance Health Inc. has a stock rating of 7 (out of 10), which is considered Good.
is Elevance Health Inc. (ELV) a good stock to buy?
As of today, Elevance Health Inc. has a Good stock rating, which is 153.3% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.